Kenny Davis Trinidad
Medical · Los Angeles, CANPI 1417088469
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Viiv Healthcare Company accounts for 79.6% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2022 at $35,661 and has fallen 59.0% since, to $14,637 in 2025. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 924 payments — averaging $107.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$79K
- Theratechnologies Inc.$7K
- Gilead$3K
- EMD Serono, Inc.$3K
- Merck$892
- Amgen$881
- plus $5K from 36 others
What the payments were for
- Consulting fees$4,3404%
- Speaking & faculty fees$50,73751%
- Travel & lodging$21,01421%
- Food & beverage$23,06223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$99,153 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SerostimSomatropin | 52 | $1,000,513 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 241 | $985,895 |
| DescovyEmtricitabine/Tenofov Alafenam | 252 | $583,846 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 122 | $572,217 |
| TivicayDolutegravir Sodium | 138 | $328,121 |
| RukobiaFostemsavir Tromethamine | 18 | $242,521 |
| JulucaDolutegravir/Rilpivirine | 54 | $193,724 |
| IsentressRaltegravir Potassium | 91 | $192,879 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 45 | $186,994 |
| PrezcobixDarunavir/Cobicistat | 77 | $186,556 |
| Egrifta SvTesamorelin Acetate | 24 | $175,587 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 26 | $105,209 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 24 | $100,707 |
| CabenuvaCabotegravir/Rilpivirine | 11 | $78,401 |
| Etravirine | 64 | $59,481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $3,382 | $1,674,949519 claims |
| Viiv Healthcare CompanyTivicay, Rukobia, Juluca, Triumeq, Cabenuva | $78,958 | $1,029,762266 claims |
| EMD Serono, Inc.Serostim | $2,736 | $1,000,51352 claims |
| MerckIsentress, Isentress Hd, Pifeltro, Januvia | $892 | $263,413138 claims |
| Johnson & JohnsonPrezcobix | $633 | $186,55677 claims |
| Theratechnologies Inc.Egrifta Sv | $6,852 | $175,58724 claims |
| Novo NordiskOzempic | $125 | $48,34046 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $365 | $28,68835 claims |
| Lilly USA, LLCMounjaro | $343 | $16,01115 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $55 | $6,40912 claims |
| GSKIncruse Ellipta | $137 | $3,79811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.
Other medical in Los Angeles
- Jeffrey BonnaudLos Angeles$314K
- Cheiny ShiauLos Angeles$86K
- Xochitl RentelnLos Angeles$38K
- Charlotte CarlsonLos Angeles$30K
- Dorna YaghoobzadehLos Angeles$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.